Published in Hepatology on June 01, 1998
Efficacy of immunosuppression monotherapy after liver transplantation: a meta-analysis. World J Gastroenterol (2014) 1.40
A prospective, randomized trial of complete avoidance of steroids in liver transplantation with follow-up of over 7 years. HPB (Oxford) (2012) 0.81
Corticosteroid-free immunosuppression in liver transplantation: an evidence-based review. World J Gastroenterol (2014) 0.75
Transarterial oily chemoembolization for the treatment of hepatocellular carcinoma: a multivariate analysis of prognostic factors. Hepatology (1994) 1.37
Portal thrombosis in cirrhotics. A retrospective analysis. Ann Surg (1986) 1.35
The role of spontaneous portosystemic shunts in the course of orthotopic liver transplantation. Transpl Int (1992) 1.15
Reappraisal of surgical treatment of small hepatocellular carcinomas in cirrhosis: clinicopathological study of resection or transplantation. Dig Dis Sci (1989) 1.10
Hepatocellular carcinoma: comparison between liver transplantation, resective surgery, ethanol injection, and chemoembolization. Transpl Int (1998) 1.09
Long-term beneficial effects in sustained responders to interferon-alfa therapy for chronic hepatitis C. J Hepatol (2001) 1.09
Rapid disappearance of hepatic adenoma after contraceptive withdrawal. J Clin Gastroenterol (2001) 1.02
Nadolol can prevent the first gastrointestinal bleeding in cirrhotics: a prospective, randomized study. Hepatology (1988) 1.01
Long-term efficacy of endoscopic stenting in patients with stricture of the biliary anastomosis after orthotopic liver transplantation. Endoscopy (1998) 1.00
Long term response to therapy of chronic anti-HBe-positive hepatitis B is poor independent of type and schedule of interferon. Am J Gastroenterol (1999) 0.97
Repeated paracentesis and i.v. albumin infusion to treat 'tense' ascites in cirrhotic patients. A safe alternative therapy. J Hepatol (1987) 0.97
Electron immunocytochemical localization of Actinobacillus actinomycetemcomitans leukotoxin. Oral Microbiol Immunol (1992) 0.95
Is hepatocellular carcinoma in cirrhosis an actual indication for liver transplantation? Transplant Proc (1997) 0.94
Antibody responses to hepatitis C virus hypervariable region 1: evidence for cross-reactivity and immune-mediated sequence variation. Hepatology (1999) 0.94
Recurrent HCV hepatitis after liver transplantation. Lancet (1993) 0.94
Biliary complications in orthotopic liver transplantation: experience with a modified technique of duct-to-duct reconstruction. Transpl Int (1991) 0.93
Long-term oral branched-chain amino acid treatment in chronic hepatic encephalopathy. A randomized double-blind casein-controlled trial. The Italian Multicenter Study Group. J Hepatol (1990) 0.93
Quantitative analysis of IgM anti-HBc in chronic hepatitis B patients using a new "gray-zone" for the evaluation of "borderline" values. J Hepatol (1996) 0.92
Fluctuations in viremia, aminotransferases and IgM antibody to hepatitis B core antigen in chronic hepatitis B patients with disease exacerbations. Liver (1994) 0.92
Breakthrough during recombinant interferon alfa therapy in patients with chronic hepatitis C virus infection: prevalence, etiology, and management. Hepatology (1995) 0.92
Intrafamilial transmission of hepatitis C virus. Lancet (1990) 0.91
The role of transplantation in small hepatocellular carcinoma complicating cirrhosis of the liver. J Am Coll Surg (1994) 0.90
Thrombosis of portal vein in absence of hepatic disease. Surg Gynecol Obstet (1989) 0.88
Hepatitis C virus RNA profiles in chronically infected individuals: do they relate to disease activity? Hepatology (1999) 0.86
Lamivudine treatment for acute hepatitis B after liver transplantation. J Hepatol (1998) 0.86
Urinary D-glucaric acid excretion in the Seveso area, polluted by tetrachloro-dibenzo-p-dioxin (TCDD): five years of experience. Environ Health Perspect (1985) 0.85
Liver transplantation for hepatocellular carcinoma: prognostic factors associated long-term survival. Transpl Int (1996) 0.85
Dynamics of hypervariable region 1 variation in hepatitis C virus infection and correlation with clinical and virological features of liver disease. Hepatology (1998) 0.85
Semiquantitative assessment of IgM antibody to hepatitis B core antigen and prediction of the severity of chronic hepatitis B. J Viral Hepat (1999) 0.84
Metabolically healthy polycystic ovary syndrome (MH-PCOS) and metabolically unhealthy polycystic ovary syndrome (MU-PCOS): a comparative analysis of four simple methods useful for metabolic assessment. Hum Reprod (2013) 0.84
Increased urinary D-glucaric acid excretion by children living in an area polluted with tetrachlorodibenzoparadioxin (TCDD). Clin Chim Acta (1982) 0.83
[Surgical treatment of hepatocellular carcinoma: resection or transplantation? Results of a multivariate analysis]. Chir Ital (2001) 0.83
Surgical treatment of symptomatic giant hemangiomas of the liver. Surg Gynecol Obstet (1992) 0.83
Is lymphocele in renal transplantation an avoidable complication? Am J Surg (2000) 0.83
Hepatic adenoma and focal nodular hyperplasia: diagnosis and criteria for treatment. Liver Transpl Surg (1997) 0.83
Early steroid withdrawal in liver transplant patients: final report of a prospective randomized trial. Transplant Proc (1997) 0.82
Treatment of HCC: the role of liver resection in the era of transplantation. Transplant Proc (2001) 0.80
HGV/GBV-C infection in liver transplant recipients: antibodies to the viral E2 envelope glycoprotein protect from de novo infection. J Hepatol (1998) 0.80
Hepatitis C virus genotypes, hepatitis, and hepatitis C virus recurrence after liver transplantation. Liver Transpl Surg (1996) 0.80
Emergence of hepatitis B virus S gene mutant in a liver transplant recipient. J Med Virol (1995) 0.80
Kaposi's sarcoma in liver transplant recipients: morphological and clinical description. Liver Transpl (2001) 0.79
Biochemical and histochemical estimations of liver gamma-glutamyltransferase activity in ethanol-fed rats. J Clin Chem Clin Biochem (1980) 0.79
Liver retransplantation: indications and results over a 15-year experience. Transplant Proc (2001) 0.79
Combined therapy with interferon and low-dose ribavirin in posttransplantation recurrent hepatitis C: a pragmatic study. Liver Transpl (2001) 0.79
Right lobe living-related liver transplant: experience at Niguarda Hospital. Transplant Proc (2003) 0.78
Antibodies developing against a single recombinant interferon protein may neutralize many other interferon-alpha subtypes. J Interferon Res (1993) 0.78
Marginal donors in liver transplantation: the role of donor age. Transplant Proc (1999) 0.78
Early ribavirin treatment and avoidance of corticosteroids in hepatitis C virus (HCV)-positive liver transplant recipients: interim report of a prospective randomized trial. Transplant Proc (2001) 0.78
Alpha interferon treatment in chronic hepatitis C. Clin Exp Rheumatol (1996) 0.78
Guidelines for completing the Perioperative Anesthesia Record. Minerva Anestesiol (2002) 0.78
Selection criteria for liver transplantation: preliminary experience of Niguarda Hospital, Milan. Transplant Proc (1989) 0.78
Right hemiliver transplants from living donors: report of 10 cases. Transplant Proc (2004) 0.78
Hepatitis C virus in non-Hodgkin's lymphoma. A reappraisal after a prospective case-control study of 300 patients. Lombart Study Group of HCV-Lymphoma. Am J Hematol (2000) 0.78
Cyclosporin monotherapy (after 3 months) in liver transplant patients: a prospective randomized trial. Transplant Proc (1994) 0.77
Role of IgM antibody to hepatitis B core antigen in the diagnosis of hepatitis B exacerbations. Arch Virol Suppl (1993) 0.77
Quantitative detection of hepatitis C virus RNA in the serum of patients with chronic hepatitis C treated with interferon: a pilot study. Clin Diagn Virol (1997) 0.77
Right hemiliver transplants from cadavers or living donors: a comparative analysis. Transplant Proc (2004) 0.77
Gynaecomastia after spironolactone and potassium canrenoate. Lancet (1986) 0.77
Low incidence of acute rejection in kidney grafts treated with initial quadruple therapy: a retrospective analysis comparing two ATGs. Transplant Proc (1998) 0.77
Italian guidelines for diagnosis, prevention, and treatment of invasive fungal infections in solid organ transplant recipients. Transplant Proc (2011) 0.77
Is the use of marginal donors justified in liver transplantation? Analysis of results and proposal of modern criteria. Transpl Int (1996) 0.76
Serum lipid changes in liver transplantation: effect of steroids withdrawn in a prospective randomized trial under cyclosporine A therapy. Transplant Proc (1999) 0.76
Long-term efficacy of endoscopic stenting in patients with stricture of the biliary anastomosis after orthotopic liver transplantation. Transplant Proc (2001) 0.76
Hepatocellular carcinoma: pathogenetic implications of the hepatitis delta virus. Prog Clin Biol Res (1993) 0.76
The anti-ischemic drugs defibrotide and oligotide analogously inhibit leukocyte-endothelial cell adhesion in vitro. Transpl Int (1996) 0.76
Incidence of sepsis in central venous catheter-bearing patients with hematologic malignancies: preliminary results. J Vasc Access (2006) 0.76
Early pancreas retransplantation for vascular thrombosis in simultaneous pancreas-kidney transplants. Transplant Proc (1998) 0.76
Clinical relevance of anti-interferon antibodies in the serum of chronic hepatitis C patients treated with interferon-alpha. J Interferon Cytokine Res (1997) 0.75
Breakthrough of interferon therapy. Am J Gastroenterol (1996) 0.75
Blood pressure instability, liver transplant surgery and optimization strategies: the Brunelleschi perspective. Minerva Anestesiol (2013) 0.75
Problems in diagnosing viral hepatitis. Gut (1993) 0.75
Recurrence of HDV infection after liver transplantation. Prog Clin Biol Res (1993) 0.75
[Clinical contribution to the study of hernia of Morgagni's foramen]. Chir Ital (1965) 0.75
Liver transplantation for small HCC in cirrhosis. Transpl Int (1992) 0.75
Incidence and clinical characteristics of posttransplant lymphoproliferative disorders: report from a single center. Transpl Int (2000) 0.75
Cost analysis of living donor liver transplantation: the first Italian economical data. Minerva Anestesiol (2007) 0.75
Orthotopic transplantation of partially hepatectomized liver in the pig. Transplantation (1987) 0.75
[Primary tumors of the mediastinum (clinico-statistical review of 31 operations)]. Chir Ital (1964) 0.75
["Renal phlebography under renal block". New exploration technic]. Presse Med (1966) 0.75
Both immunogenetic factors and HCV genotype can influence the outcome of chronic HCV infection. Am J Gastroenterol (1997) 0.75
Immunogenetic factors, HCV genotypes, and HCV recurrence after liver transplantation. Transplant Proc (1999) 0.75
Influence of immunogenetic background on the outcome of recurrent hepatitis C after liver transplantation. Hepatology (2000) 0.75
Endoscopic treatment of anastomotic biliary stenosis in patients with orthotopic liver transplantation. Diagn Ther Endosc (1995) 0.75
Left thoracic approach for cancer of cardia: early and late results. Int Surg (1997) 0.75